Takashi Yoshiyama - Publications

Asymptomatic tuberculosis in Japan: a 15-year national surveillance study, 2008-2022.

Journal: The Lancet regional health. Western Pacific

Published: December 24, 2025

Clinical outcomes of linezolid-related adverse events in patients with multidrug-resistant TB.

Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Published: December 18, 2025

Erector spinae muscle thickness predicts mortality in patients with pulmonary diseases.

Journal: Respiratory investigation

Published: October 31, 2025

Reducing the daily infusion time of peripheral parenteral nutrition to prevent bloodstream infection in hospitalized patients.

Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

Published: October 08, 2025

All-case post-marketing surveillance of delamanid for treating multidrug-resistant pulmonary tuberculosis in Japan.

Journal: Respiratory investigation

Published: August 27, 2025

Real-world effectiveness and lung abnormalities associated with amikacin liposome inhalation suspension.

Journal: Respiratory medicine

Published: April 28, 2025

Incidence of infectious diseases in children with Mycobacterium tuberculosis in Japan, 2007-2022.

Journal: Tuberculosis (Edinburgh, Scotland)

Published: April 24, 2025

Corrigendum to 'Impact of accumulative smoking exposure and chronic obstructive pulmonary disease on COVID-19 outcomes: report based on findings from the Japan COVID-19 task force' [IJID 128 (2023) 121-127].

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: December 11, 2024

Quantifying the Reversibility of Clofazimine-induced Pigmentation in a Patient with Mycobacterium abscessus Pulmonary Disease.

Journal: Internal medicine (Tokyo, Japan)

Published: November 20, 2024

Risk factors, molecular analysis and treatment outcomes of amikacin-resistant Mycobacterium avium complex pulmonary disease.

Journal: ERJ open research

Published: October 20, 2024

Evaluation of testing face-mask filter samples with LAMP shows high rates of detection in pulmonary TB.

Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Published: September 28, 2024

Predicting coronavirus disease 2019 severity using explainable artificial intelligence techniques.

Journal: Scientific reports

Published: September 07, 2024